The global diphtheria, tetanus, and pertussis (DTaP) vaccine market is witnessing significant growth due to rising immunization programs, increasing awareness about infectious diseases, and government initiatives to control disease outbreaks. According to DataIntelo, the market is projected to reach USD X.XX billion by 2032, expanding at a CAGR of X.X% during the forecast period. The demand for DTaP vaccines is driven by government-funded immunization programs, rising healthcare expenditures, and technological advancements in vaccine development. Emerging economies are playing a crucial role in expanding vaccination coverage worldwide.